Skip to main content
OpenTrials
Completed

NCT Number: NCT06011811

Cluster Headache Treatment Survey

The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with episodic or chronic cluster headache that has been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)

Exclusion criteria

  • Unable to speak English (the survey is only in English)
  • Unable to use a computer to take the online survey
  • Unable to provide consent

Treatment and study plan

Primary outcomes

  1. Effectiveness of cluster headache treatment as assessed by a survey

    Time frame: at the time of survey completion, expected to be 6-12 months

Secondary outcomes

  1. Opinions on new cluster headache treatment as assessed by a survey

    Time frame: at the time of survey completion, expected to be 6-12 months

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Collaborators

  • Clusterbusters, Inc.

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 25, 2023
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.